Decorin and chondroitin-6 sulfate inhibit B16V melanoma cell migration and invasion by cellular acidification

Journal of Cellular Physiology

Volumn 226, Issue 10, 2011, Pages 2641-2650

  Stock, Christian ^a   Jungmann, Oliver ^a   Seidler, Daniela G ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN 6 SULFATE; COLLAGEN; DECORIN; GELATINASE A; SODIUM PROTON EXCHANGE PROTEIN 1;

ACIDIFICATION; ANIMAL CELL; ARTICLE; CELL ADHESION; CELL INTERACTION; CELL INVASION; CELL MIGRATION; CELL PH; CELL SURFACE; COCULTURE; CONTROLLED STUDY; CYTOSOL; DRUG INHIBITION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FIBROBLAST; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOMA CELL; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; TIME LAPSE MICROSCOPY; TUMOR CELL LINE;

ACIDS; ANIMALS; CELL COMMUNICATION; CELL LINE, TUMOR; CELL MIGRATION INHIBITION; CHONDROITIN SULFATES; COCULTURE TECHNIQUES; DECORIN; FIBROBLASTS; HYDROGEN-ION CONCENTRATION; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; SKIN; SKIN NEOPLASMS;

EID: 79960666061     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22612     Document Type: Article

References (73)

1. Adany R, Heimer R, Caterson B, Sorrell JM, Iozzo RV. 1990. Altered expression of chondroitin sulfate proteoglycan in the stroma of human colon carcinoma. Hypomethylation of PG-40 gene correlates with increased PG-40 content and mRNA levels. J Biol Chem 265: 11389-11396.
2. Al Haj Zen A, Lafont A, Durand E, Brasselet C, Lemarchand P, Godeau G, Gogly B. 2003. Effect of adenovirus-mediated overexpression of decorin on metalloproteinases, tissue inhibitors of metalloproteinases and cytokines secretion by human gingival fibroblasts. Matrix Biol 22: 251-258.
3. Asimakopoulou AP, Theocharis AD, Tzanakakis GN, Karamanos NK. 2008. The biological role of chondroitin sulfate in cancer and chondroitin-based anticancer agents. In Vivo 22: 385-389.
4. Baici A, Horler D, Moser B, Hofer HO, Fehr K, Wagenhauser FJ. 1992. Analysis of glycosaminoglycans in human serum after oral administration of chondroitin sulfate. Rheumatol Int 12: 81-88.
5. Batzer AG, Rotin D, Urena JM, Skolnik EY, Schlessinger J. 1994. Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor. Mol Cell Biol 14: 5192-5201.
6. Brooks PC, Strömblad S, Sanders LC, von Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP, Cheresh DA. 1996. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 85: 683-693.
7. Choi IK, Lee YS, Yoo JY, Yoon AR, Kim H, Kim DS, Seidler DG, Kim JH, Yun CO. 2010. Effect of decorin on overcoming the extracellular matrix barrier for oncolytic virotherapy. Gene Ther 17: 190-201.
8. Cuello F, Snabaitis AK, Cohen MS, Taunton J, Avkiran M. 2007. Evidence for direct regulation of myocardial Na+/H+ exchanger isoform 1 phosphorylation and activity by 90-kDa ribosomal S6 kinase (RSK): Effects of the novel and specific RSK inhibitor fmk on responses to alpha1-adrenergic stimulation. Mol Pharmacol 71: 799-806.
9. Danielson KG, Fazzio A, Cohen I, Cannizzaro LA, Eichstetter I, Iozzo RV. 1993. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. Genomics 15: 146-160.
10. Danilkovitch-Miagkova A, Zbar B. 2002. Dysregulation of Met receptor tyrosine kinase activity in invasive tumors. J Clin Invest 109: 863-867.
11. Denholm EM, Lin YQ, Silver PJ. 2001. Anti-tumor activities of chondroitinase AC and chondroitinase B: Inhibition of angiogenesis, proliferation and invasion. Eur J Pharmacol 416: 213-221.
12. Ferdous Z, Wei VM, Iozzo R, Hook M, Grande-Allen KJ. 2007. Decorin-transforming growth factor-interaction regulates matrix organization and mechanical characteristics of three-dimensional collagen matrices. J Biol Chem 282: 35887-35898.
13. Ferdous Z, Peterson SB, Tseng H, Anderson DK, Iozzo RV, Grande-Allen KJ. 2010. A role for decorin in controlling proliferation, adhesion, and migration of murine embryonic fibroblasts. J Biomed Mater Res A 93: 419-428.
14. Fiedler LR, Schönherr E, Waddington R, Niland S, Seidler DG, Aeschlimann D, Eble JA. 2008. Decorin regulates endothelial cell motility on collagen I through activation of insulin-like growth factor I receptor and modulation of alpha2beta1 integrin activity. J Biol Chem 283: 17406-17415.
15. Frantz C, Barreiro G, Dominguez L, Chen X, Eddy R, Condeelis J, Kelly MJ, Jacobson MP, Barber DL. 2008. Cofilin is a pH sensor for actin free barbed end formation: Role of phosphoinositide binding. J Cell Biol 183: 865-879.
16. Fthenou E, Zong F, Zafiropoulos A, Dobra K, Hjerpe A, Tzanakakis GN. 2009. Chondroitin sulfate A regulates fibrosarcoma cell adhesion, motility and migration through JNK and tyrosine kinase signaling pathways. In Vivo 23: 69-76.
17. Ganz MB, Boyarsky G, Boron WF, Sterzel RB. 1988. Effects of angiotensin II and vasopressin on intracellular pH of glomerular mesangial cells. Am J Physiol 254: F787-F794.
18. Garrigues HJ, Lark MW, Lara S, Hellstrom I, Hellstrom KE, Wight TN. 1986. The melanoma proteoglycan: Restricted expression on microspikes, a specific microdomain of the cell surface. J Cell Biol 103: 1699-1710.
19. Goldoni S, Humphries A, Nystrom A, Sattar S, Owens RT, McQuillan DJ, Ireton K, Iozzo RV. 2009. Decorin is a novel antagonistic ligand of the Met receptor. J Cell Bioll 185: 743-754.
20. Goldoni S, Seidler DG, Heath J, Fassan M, Baffa R, Thakur ML, Owens RT, McQuillan DJ, Iozzo RV. 2008. An antimetastatic role for decorin in breast cancer. Am J Pathol 173: 844-855.
21. Gong W, Zhang G-M, Liu Y, Lei Z, Li D, Yuan Y, Huang B, Feng Z-H. 2008. IFN-γ withdrawal after immunotherapy potentiates B16 melanoma invasion and metastasis by intensifying tumor integrin αvβ3 signaling. Int J Cancer 123: 702-708.
22. Gu J, Wada Y. 1996. Effect of exogenous decorin on cell morphology and attachment of decorin-deficient fibroblasts. J Biochem 119: 743-748.
23. Hofmann UB, Houben R, Bröcker EB, Becker JC. 2005. Role of matrix metalloproteinases in melanoma cell invasion. Biochimie 87: 307-314.
24. Iida J, Wilhelmson KL, Ng J, Lee P, Morrison C, Tam E, Overall CM, McCarthy JB. 2007. Cell surface chondroitin sulfate glycosaminoglycan in melanoma: Role in the activation of pro-MMP-2 (pro-gelatinase A). Biochem J 403: 553-563.
25. Imai K, Hiramatsu A, Fukushima D, Pierschbacher MD, Okada Y. 1997. Degradation of decorin by matrix metalloproteinases: Identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release. Biochem J 322: 809-814.
26. Iozzo RV. 1997. The family of the small leucine-rich proteoglycans: Key regulators of matrix assembly and cellular growth. Crit Rev Biochem Mol Biol 32: 141-174.
27. Kähnert H, Brinkmann T, Gässler N, Kleesiek K. 1994. Determination of chondroitin-6-sulphate by a competitive enzyme immunoassay using a biotinylated antigen. Eur J Clin Chem Clin Biochem 32: 293-299.
28. Kanekura T, Chen X, Kanzaki T. 2002. Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts. Int J Cancer 99: 520-528.
29. Kato Y, Nakayama Y, Umeda M, Miyazaki K. 1992. Induction of 103-kDa gelatinase/type IV collagenase by acidic culture conditions in mouse metastatic melanoma cell lines. J Biol Chem 267: 11424-11430.
30. Kirschberger S, Busche R, von Engelhardt W. 1999. Surface pH at the basolateral membrane of the caecal mucosa of guinea pig. J Membr Biol 169: 111-122.
31. Kovbasnjuk ON, Spring KR. 2000. The apical membrane glycocalyx of MDCK cells. J Membr Biol 176: 19-29.
32. Krähling H, Mally S, Eble JA, Noel J, Schwab A, Stock C. 2009. The glycocalyx maintains a cell surface pH nanoenvironment crucial for integrin-mediated migration of human melanoma cells. Pflugers Arch 458: 1069-1083.
33. Kresse H, Schönherr E. 2001. Proteoglycans of the extracellular matrix and growth control. J Cell Physiol 189: 266-274.
34. Löffek S, Zigrino P, Angel P, Anwald B, Krieg T, Mauch C. 2005. High invasive melanoma cells induce matrix metalloproteinase-1 synthesis in fibroblasts by interleukin-1alpha and basic fibroblast growth factor-mediated mechanisms. J Invest Dermatol 124: 638-643.
35. Löffek S, Zigrino P, Mauch C. 2006. Tumor-stroma interactions: Their role in the control of tumor cell invasion and metastasis. J Dtsch Dermatol Ges 4: 496-502.
36. Merle B, Durussel L, Delmas PD, Clezardin P. 1999. Decorin inhibits cell migration through a process requiring its glycosaminoglycan side chain. J Cell Biochem 75: 538-546.
37. Ohnishi Y, Tajima S, Ishibashi A. 2001. Coordiante expression of membrane type-matrix metalloproteinases-2 and 3 (MT2-MMP and MT3-MMP) and matrix metalloprotease-2 (MMP-2) in primary and metastatic melanoma cells. Eur J Dermatol 11: 420-423.
38. Orgel JP, Irving TC, Miller A, Wess TJ. 2006. Microfibrillar structure of type I collagen in situ. Proc Natl Acad Sci USA 103: 9001-9005.
39. Pouysségur J, Sardet C, Franchi A, L'Allemain G, Paris S. 1984. A specific mutation abolishing Na+/H+ antiport activity in hamster fibroblasts precludes growth at neutral and acidic pH. Proc Natl Acad Sci USA 81: 4833-4837.
40. Ranta V, Mikkola T, Ylikorkala O, Viinikka L, Orpana A. 1998. Reduced viability of human vascular endothelial cells cultured on Matrigel. J Cell Physiol 176: 92-98.
41. Reed CC, Gauldie J, Iozzo RV. 2002. Suppression of tumorigenicity by adenovirus-mediated gene transfer of Decorin. Oncogene 21: 3688-3695.
42. Reed CC, Waterhouse A, Kirby S, Kay P, Owens RT, McQuillan DJ, Iozzo RV. 2005. Decorin prevents metastatic spreading of breast cancer. Oncogene 24: 1104-1110.
43. Rühland C, Schönherr E, Robenek H, Hansen H, Iozzo RV, Bruckner P, Seidler DG. 2007. The glycosaminoglycan chain of decorin plays an important role in collagen fibril formation at the early stages of fibrillogenesis. FEBS J 274: 4246-4255.
44. Santra M, Skorski T, Calabretta B, Lattime EC, Iozzo RV. 1995. De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells. Proc Natl Acad Sci USA 92: 7016-7020.
45. Schaefer L, Iozzo RV. 2008. Biological functions of the small leucine-rich proteoglycans: From genetics to signal transduction. J Biol Chem 283: 21305-21309.
46. Schaefer L, Raslik I, Grone HJ, Schönherr E, Macakova K, Ugorcakova J, Budny S, Schaefer RM, Kresse H. 2001. Small proteoglycans in human diabetic nephropathy: Discrepancy between glomerular expression and protein accumulation of decorin, biglycan, lumican, and fibromodulin. FASEB J 15: 559-561.
47. Schönherr E, Levkau B, Schaefer L, Kresse H, Walsh K. 2001. Decorin-mediated signal transduction in endothelial cells. Involvement of Akt/protein kinase B in up-regulation of p21(WAF1/CIP1) but not p27(KIP1). J Biol Chem 276: 40687-40692.
48. Schönherr E, Sunderkötter C, Schaefer L, Thanos S, Grässel S, Oldberg A, Iozzo RV, Young MF, Kresse H. 2004. Decorin deficiency leads to impaired angiogenesis in injured mouse cornea. J Vasc Res 41: 499-508.
49. +-HCO3- cotransport in migration of transformed renal epithelial cells. J Physiol 568: 445-458.
50. Seidler DG, Schaefer L, Robenek H, Iozzo RV, Kresse H, Schönherr E. 2005. A physiologic three-dimensional cell culture system to investigate the role of decorin in matrix organisation and cell survival. Biochem Biophys Res Commun 332: 1162-1170.
51. Seidler DG, Goldoni S, Agnew C, Cardi C, Thakur ML, Owens RT, McQuillan DJ, Iozzo RV. 2006. Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation. J Biol Chem 281: 26408-26418.
52. Smetsers TF, van de Westerlo EM, ten Dam GB, Overes IM, Schalkwijk J, van Muijen GN, van Kuppevelt TH. 2004. Human single-chain antibodies reactive with native chondroitin sulfate detect chondroitin sulfate alterations in melanoma and psoriasis. J Invest Dermatol 122: 707-716.
53. Srivastava J, Barreiro G, Groscurth S, Gingras AR, Goult BT, Critchley DR, Kelly MJ, Jacobson MP, Barber DL. 2008. Structural model and functional significance of pH-dependent talin-actin binding for focal adhesion remodeling. Proc Natl Acad Sci USA 105: 14436-14441.
54. Stanton H, Gavrilovic J, Atkinson SJ, d'Ortho MP, Yamada KM, Zardi L, Murphy G. 1998. The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form. J Cell Sci 111: 2789-2798.
55. Stock C, Schwab A. 2009. Protons make tumor cells move like clockwork. Pflugers Arch 458: 1069-1083.
56. + exchange. J Physiol 567: 225-238.
57. Stock C, Mueller M, Kraehling H, Mally S, Noel J, Eder C, Schwab A. 2007. pH nanoenvironment at the surface of single melanoma cells. Cell Physiol Biochem 20: 679-686.
58. Stock C, Cardone RA, Busco G, Krahling H, Schwab A, Reshkin SJ. 2008. Protons extruded by NHE1: Digestive or glue? Eur J Cell Biol 87: 591-599.
59. Stüwe L, Muller M, Fabian A, Waning J, Mally S, Noel J, Schwab A, Stock C. 2007. pH dependence of melanoma cell migration: Protons extruded by NHE1 dominate protons of the bulk solution. J Physiol 585: 351-360.
60. Supino R, Prosperi E, Formelli F, Mariani M, Parmiani G. 1986. Characterization of a doxorubicin-resistant murine melanoma line: Studies on cross-resistance and its circumvention. Br J Cancer 54: 33-42.
61. Taylor KR, Gallo RL. 2006. Glycosaminoglycans and their proteoglycans: Host-associated molecular patterns for initiation and modulation of inflammation. FASEB J 20: 9-22.
62. Troup S, Njue C, Kliewer EV, Parisien M, Roskelley C, Chakravarti S, Roughley PJ, Murphy LC, Watson PH. 2003. Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. Clin Cancer Res 9: 207-214.
63. van Muijen GN, Jansen KF, Cornelissen IM, Smeets DF, Beck JL, Ruiter DJ. 1991. Establishment and characterization of a human melanoma cell line (MV3) which is highly metastatic in nude mice. Int J Cancer 48: 85-91.
64. Wegrowski Y, Maquart FX. 2004. Involvement of stromal proteoglycans in tumour progression. Crit Rev Oncol Hematol 49: 259-268.
65. Wegrowski Y, Maquart FX. 2006. Chondroitin sulfate proteoglycans in tumor progression. Adv Pharmacol 53: 297-321.
66. Winnemöller M, Schmidt G, Kresse H. 1991. Influence of decorin on fibroblast adhesion to fibronectin. Eur J Cell Biol 54: 10-17.
67. Wolf K, Alexander S, Schacht V, Coussens LM, von Andrian UH, van Rheenen J, Deryugina E, Friedl P. 2009. Collagen-based cell migration models in vitro and in vivo. Semin Cell Dev Biol 20: 931-941.
68. Yamada S, Sugahara K. 2008. Potential therapeutic application of chondroitin sulfate/dermatan sulfate. Curr Drug Discov Technol 5: 289-301.
69. Yang X, Wang D, Dong W, Song Z, Dou K. 2010. Suppression of Na(+)/H (+) exchanger 1 by RNA interference or amiloride inhibits human hepatoma cell line SMMC-7721 cell invasion. Med Oncol. [Epub ahead of print].
70. Zamfir AD, Flangea C, Sisu E, Serb AF, Dinca N, Bruckner P, Seidler DG. 2009. Analysis of novel over- and under-sulfated glycosaminoglycan sequences by enzyme cleavage and multiple stage MS. Proteomics 9: 3435-3444.
71. Zhu JX, Goldoni S, Bix G, Owens RT, McQuillan DJ, Reed CC, Iozzo RV, 2005. Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar endocytosis. J Biol Chem 280: 32468-32479.
72. Zou XH, Foong WC, Cao T, Bay BH, Ouyang HW, Yip GW. 2004. Chondroitin sulfate in palatal wound healing. J Dent Res 83: 880-885.
73. Zou XH, Jiang YZ, Zhang GR, Jin HM, Nguyen TM, Ouyang HW. 2009. Specific interactions between human fibroblasts and particular chondroitin sulfate molecules for wound healing. Acta Biomater 5: 1588-1595.